Clinical trial
Reducing HIV Risk Among Pregnant Women in Drug Treatment
NCT00332813 · Rhode Island Hospital, Other · Completed
Key facts
| NCT number | NCT00332813 |
|---|---|
| Title | Reducing HIV Risk Among Pregnant Women in Drug Treatment |
| Official title | Reducing HIV Risk Among Pregnant Women in Drug Treatment |
| Lead sponsor | Rhode Island Hospital, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | HIV Risk Behavior |
| Intervention type | Behavioral |
| Interventions | HIV Risk Behavior Intervention |
| Enrollment | 98 |
| Start date | Feb 1, 2006 |
| Primary completion | Oct 1, 2010 |
| Completion | Oct 1, 2010 |
| First posted | Jun 2, 2006 |
| Last update posted | Mar 28, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: